Edition:
United Kingdom

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

5,670JPY
4:40am GMT
Change (% chg)

¥130 (+2.35%)
Prev Close
¥5,540
Open
¥5,630
Day's High
¥5,760
Day's Low
¥5,610
Volume
119,100
Avg. Vol
152,980
52-wk High
¥6,090
52-wk Low
¥2,133

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 23 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.14 2.14 2.14

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1 5,600.00 5,600.00 5,600.00 --
Year Ending Mar-18 6 20,438.70 20,662.00 20,300.00 20,057.80
Year Ending Mar-19 6 21,819.80 22,600.00 21,140.00 21,365.00
Earnings (per share)
Year Ending Mar-18 7 83.42 91.00 64.30 74.09
Year Ending Mar-19 7 92.28 126.90 67.50 92.98
LT Growth Rate (%) 1 30.21 30.21 30.21 12.63

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 5,300.00 5,801.00 501.00 9.45
Quarter Ending Mar-15 4,311.00 4,539.00 228.00 5.29
Quarter Ending Dec-14 3,950.00 4,160.95 210.95 5.34
Quarter Ending Sep-14 4,410.00 4,343.89 66.11 1.50
Quarter Ending Jun-14 3,690.00 3,811.49 121.49 3.29

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 5,600.00 5,600.00 5,600.00 5,600.00 --
Year Ending Mar-18 20,438.70 20,438.70 20,438.70 20,233.10 20,057.80
Year Ending Mar-19 21,819.80 21,819.80 21,819.80 21,659.90 21,365.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Year Ending Mar-18 0 0 0 0
Year Ending Mar-19 0 0 0 0
Earnings